A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/03/2011	WO2011136956A1 Use of selective estrogen receptor modulator for joint fusion and other healing
11/03/2011	WO2011136927A1 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/03/2011	WO2011136754A1 A medicament developed for the treatment of respiratory diseases
11/03/2011	WO2011136753A1 Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
11/03/2011	WO2011136752A1 Combined pharmaceutical composition comprising carmoterol and ciclesonide for the treatment of respiratory diseases
11/03/2011	WO2011136750A1 Pharmaceutical compositions inducing synergistic effect
11/03/2011	WO2011136723A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/03/2011	WO2011136700A2 Agent exhibiting the properties of a cognitive function promoter (embodiments)
11/03/2011	WO2011136691A1 Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases
11/03/2011	WO2011136648A1 Use of human milk oligosaccharides in infant nutrition
11/03/2011	WO2011136647A1 Use of 6'-sialyl lactose in infant and toddler nutrition
11/03/2011	WO2011136637A1 Use of human milk oligosaccharides in infant nutrition
11/03/2011	WO2011136636A1 Use of 6'-sialyl lactose in infant nutrition
11/03/2011	WO2011136634A1 Preventing salmonella infection induced weight loss
11/03/2011	WO2011136585A2 Composition for treating bone disease comprising a glyceollin as an active ingredient
11/03/2011	WO2011136561A2 Composition for the treatment of vitiligo, containing serotonin as an active ingredient
11/03/2011	WO2011136399A1 Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer
11/03/2011	WO2011136385A1 Bicyclic compound derivatives and their use as acc inhibitors.
11/03/2011	WO2011136376A1 Enteric tablet
11/03/2011	WO2011136373A1 Enteric tablet
11/03/2011	WO2011136319A1 Anticancer agent
11/03/2011	WO2011136318A1 Therapeutic agent and preventative agent for alzheimer's disease
11/03/2011	WO2011136308A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
11/03/2011	WO2011136307A1 Prophylactic or therapeutic agent for night urination
11/03/2011	WO2011136292A1 Novel amide derivative and use thereof as medicine
11/03/2011	WO2011136288A1 Transdermally absorbable donepezil-containing preparation
11/03/2011	WO2011136283A1 Skin irritation suppressant and transdermal preparation
11/03/2011	WO2011136269A1 Tetrahydrobenzothiophene compound
11/03/2011	WO2011136268A1 Novel cephem derivative
11/03/2011	WO2011136264A1 [5,6] heterocyclic compound
11/03/2011	WO2011136247A1 Novel heteroaryl monocyclic pyrimidine derivative
11/03/2011	WO2011136192A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
11/03/2011	WO2011136161A1 Prophylactic or therapeutic medication for inner ear disorders
11/03/2011	WO2011136159A1 Composition for the treatment of aesthenopia
11/03/2011	WO2011135784A1 Anti-brain-tumor drug
11/03/2011	WO2011135743A1 Medicinal agent for prevention and/or treatment of hepatitis c
11/03/2011	WO2011135591A2 Novel tablet composition of polyallylamine polymers
11/03/2011	WO2011135582A2 Pharmaceutical compositions of dronedarone
11/03/2011	WO2011135581A2 Pharmaceutical compositions of dronedarone
11/03/2011	WO2011135578A1 Composition comprising chitin and tinosporin for use in the treatment of viral diseases
11/03/2011	WO2011135577A1 Polyhexamethyleneguanidine and its salts based disinfectant.
11/03/2011	WO2011135574A1 Methods, compositions and kits for providing a therapeutic treatment
11/03/2011	WO2011135564A1 Methods and lipid compositions for promoting development of gut flora
11/03/2011	WO2011135563A1 Metal entrapped bioactive composites
11/03/2011	WO2011135520A1 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
11/03/2011	WO2011135519A1 A capsicum annuum extract and process thereof
11/03/2011	WO2011135430A1 Controlled release pharmaceutical compositions of brivaracetam
11/03/2011	WO2011135426A1 Solid oral dosage forms comprising tadalafil
11/03/2011	WO2011135401A1 Polysaccharides comprising carboxyl functional groups substituted by esterification by a hydrophobic alcohol
11/03/2011	WO2011135400A1 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
11/03/2011	WO2011135376A1 Pyrazolyl quinazoline kinase inhibitors
11/03/2011	WO2011135355A1 3-{ [5 -(azetidin-1-ylcarbonyl)pyrazin-2 -yl] oxy} -5-{ [(1s) -2 -hydroxy- 1 -methylethyl]oxy} -n- (5 -methylpyrazin-2-) benzamid monohydrate
11/03/2011	WO2011135351A1 Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases
11/03/2011	WO2011135332A2 Nmn modulator
11/03/2011	WO2011135314A2 Pharmaceutical powder compositions
11/03/2011	WO2011135303A2 Ubiquitination modulators
11/03/2011	WO2011135276A1 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -hsd1
11/03/2011	WO2011135259A1 Pyrido[3,2-d]pyrimidine derivatives, processes for preparing same and therapeutic uses thereof
11/03/2011	WO2011135200A1 Dermatological composition based on argan oil and hyaluronic acid
11/03/2011	WO2011135140A1 Method for the delivery of oligonucleotides
11/03/2011	WO2011135107A1 Compositions for the symptomatic relief of stomach pain or gastro-oesophageal reflux
11/03/2011	WO2011135106A1 Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for the obtainment thereof
11/03/2011	WO2011135105A1 Improved process for preparing rufinamide intermediate
11/03/2011	WO2011135090A1 Method for treating scars with adapalene 0.3%
11/03/2011	WO2011135073A1 Adhesive slow-release formulations for the local administration of curcumin
11/03/2011	WO2011135020A1 Use of a composition containing phospholipids and glycyrrhizinic acid for removing subcutaneous fat accumulations by means of subcutaneous lipolysis
11/03/2011	WO2011135007A1 New compounds, synthesis and use thereof in the treatment of pain
11/03/2011	WO2011134971A1 7-(1h-pyrazol-4-yl)-1,6-naphthyridine compounds as syk inhibitors
11/03/2011	WO2011134962A2 Orally disintegrating tablet containing acarbose
11/03/2011	WO2011134954A1 Anticancer steroidal lactones unsaturated in position 7 (8)
11/03/2011	WO2011134944A2 Low-oil pharmaceutical emulsion compositions comprising progestogen
11/03/2011	WO2011134937A2 Pharmaceutical emulsion compositions comprising progestogen
11/03/2011	WO2011134925A1 Spiroindolinone pyrrolidines
11/03/2011	WO2011134899A1 Combination therapy of an afucosylated cd20 antibody with a mtor inhibitor
11/03/2011	WO2011134898A1 New combination therapy in treatment of oncological and fibrotic diseases
11/03/2011	WO2011134877A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/03/2011	WO2011134846A1 Oral dosage forms
11/03/2011	WO2011134831A1 Pyrazole compounds as jak inhibitors
11/03/2011	WO2011134763A1 Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers
11/03/2011	WO2011134675A1 Carrier and targeting system comprising a siosomal composition for intracellular delivery and targeting of active substance
11/03/2011	WO2011134538A1 Diyne compositions
11/03/2011	WO2011134478A2 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
11/03/2011	WO2011134369A1 Pharmaceutical composition for improving solubility of prasugrel and its preparation method
11/03/2011	WO2011134368A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
11/03/2011	WO2011134296A1 (6,7-dihydro-2-nitro-5h-imidazol[2,1-b] [1,3]oxazin-6-yl) amide compounds, preparation methods and uses thereof
11/03/2011	WO2011134283A1 Matrinic acid/ matrine derivatives and preparation methods and uses thereof
11/03/2011	WO2011134280A1 Compounds as agonists of s1p1 receptors
11/03/2011	WO2011134275A1 Metal complexes of thiourea and their derivatives as metal delivering anti-cancer and anti-inflammatory agents
11/03/2011	WO2011134271A1 Use of kukoamine a and kukoamine b
11/03/2011	WO2011134191A1 Compound pharmaceutical formulation
11/03/2011	WO2011134140A1 Pyrimidinyl indole compounds
11/03/2011	WO2011134119A1 7,2''-dehydrated puerarin, its salts derivatives, and its preparative methods and uses
11/03/2011	WO2011134101A1 New crystalline form n of febuxostat and preparation method thereof
11/03/2011	WO2011134098A1 Method for inhibiting tau protein aggregation and treatment of alzheimer's disease with a compound derived from quinoline
11/03/2011	WO2011134084A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders
11/03/2011	WO2011134075A1 Sox9 inhibitors
11/03/2011	WO2011134019A1 Novel biphenyl sartans
11/03/2011	WO2011112689A3 Salts of an indazolylpyrrolotriazine
11/03/2011	WO2011107653A3 Use of levodopa, carbidopa and entacapone for treating parkinson's disease
11/03/2011	WO2011107649A3 Peritoneal dialysis solution comprising aliskiren

1 ... 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 ... 7860